Therapy for Rare Bone Disorder Shows Promise in NIH Clinical Trial
Medication is the first to reduce bone-weakening process in patients with fibrous dysplasia. April...
Read MoreMedication is the first to reduce bone-weakening process in patients with fibrous dysplasia. April...
Read MoreDr. Jean Monice, Pediatric Medical Director HOMETOWN HERE: LOCAL PEDIATRICIAN WORKING TO PROVIDE...
Read MoreApril 4, 2023 – Commenting April 4 on topics discussed by the Medicare Payment Advisory Commission in March, AHA said it continues to strongly oppose additional site-neutral payment cuts to hospital outpatient departments,...
Read MoreMarch 23, 2023 – County and specialty medical societies are invited to nominate eligible...
Read MoreBy Jarrod Fowler, MHA, FMA Director of Healthcare Policy and Innovation March 30, 2023- With advancements in artificial intelligence (AI) constantly appearing in the news, some of you might be wondering what the FMA’s policy is...
Read More